New horizons in treatment of osteoporosis
Background Prevalence of osteoporosis is increasing both in developed and developing
countries. Due to rapid growth in the burden and cost of osteoporosis, worldwide, it seems …
countries. Due to rapid growth in the burden and cost of osteoporosis, worldwide, it seems …
Pharmacological therapy of osteoporosis: a systematic current review of literature
Osteoporosis is the most common bone disease affecting millions of people worldwide,
particularly in elderly or in post-menopausal women. The pathogenesis is useful to …
particularly in elderly or in post-menopausal women. The pathogenesis is useful to …
Therapeutic treatments for osteoporosis—which combination of Pills is the best among the bad?
CH Tonk, SH Shoushrah, P Babczyk… - International journal of …, 2022 - mdpi.com
Osteoporosis is a chronical, systemic skeletal disorder characterized by an increase in bone
resorption, which leads to reduced bone density. The reduction in bone mineral density and …
resorption, which leads to reduced bone density. The reduction in bone mineral density and …
[HTML][HTML] Drugs for the management of osteoporosis: a review
DK Khajuria, R Razdan, DR Mahapatra - Revista brasileira de …, 2011 - SciELO Brasil
A osteoporose caracteriza-se por reduzida massa óssea e deterioração microarquitetural do
tecido ósseo, o que aumenta a fragilidade óssea e, portanto, a suscetibilidade a fraturas. A …
tecido ósseo, o que aumenta a fragilidade óssea e, portanto, a suscetibilidade a fraturas. A …
Current, new and future treatments of osteoporosis
P Salari Sharif, M Abdollahi, B Larijani - Rheumatology international, 2011 - Springer
Osteoporosis as a common chronic disease is challenging human health. Although different
therapeutic options are routinely used for prevention/treatment of osteoporosis, their side …
therapeutic options are routinely used for prevention/treatment of osteoporosis, their side …
Osteoporosis therapies and their mechanisms of action
B Kim, YJ Cho, W Lim - Experimental and therapeutic …, 2021 - spandidos-publications.com
Osteoporosis is a common disease that affects millions of patients worldwide and is most
common in menopausal women. The main characteristics of osteoporosis are low bone …
common in menopausal women. The main characteristics of osteoporosis are low bone …
An overview of the management of osteoporosis in the aging female population
U Amin, A McPartland, M O'Sullivan… - Women's Health, 2023 - journals.sagepub.com
Osteoporosis is a systemic skeletal disease that is a cause of morbidity and mortality. It can
affect all ages but most frequently postmenopausal women. It is a silent condition, however …
affect all ages but most frequently postmenopausal women. It is a silent condition, however …
Pharmacological therapy of osteoporosis: what's new?
Osteoporosis and fragility fractures are relevant health issues because of their impact in
terms of morbidity, mortality, and socioeconomic burden. Despite this alarming scenario …
terms of morbidity, mortality, and socioeconomic burden. Despite this alarming scenario …
[PDF][PDF] Pharmacological agents and natural compounds: available treatments for osteoporosis.
M Martiniakova, M Babikova, R Omelka - Journal of Physiology & …, 2020 - jpp.krakow.pl
Osteoporosis, a systemic skeletal disease characterized by a decrease in bone mass and
deterioration of bone structure leading to an increased risk of fragility fractures, represents …
deterioration of bone structure leading to an increased risk of fragility fractures, represents …
[PDF][PDF] Osteoporosis-risk factors, pharmaceutical and non-pharmaceutical treatment.
W Tański, J Kosiorowska… - European Review for …, 2021 - researchgate.net
Osteoporosis is a metabolic disease of the skeletal system which currently affects over 200
million patients worldwide. The WHO criteria define osteoporosis as low bone mineral …
million patients worldwide. The WHO criteria define osteoporosis as low bone mineral …